Kiran Mazumdar Shaw

Kiran Mazumdar ShawPresented by: Prerna Nambiar Ramki Thivya Muthu Muthu Tharun Svarna

Life

Schooling at Bishop Cotton Girls School & Mount Carmel College at Bangalore

Born on 23rd March, 1953 in Bangalore

B.Sc in Zoology from Bangalore University

Qualified as a master brewer from Ballarat Universtiy, Australia

CMD, Biocon Ltd., Indias biggest Biotechnology Company

In 2004, she became Indias Richest Woman

Personal Life

John Shaw headed a leading textiles MNC, Madura Coats from 1991 to 1998 as CMD.

Kiran Mazumdar Shaw is married to John Shaw, a Scotsman and Indophile.

Currently, John Shaw is Vice-Chairman of Biocon, Ltd.

She has huge collections of paintings and other art works.

She has also written a coffee table book named Ale & Arty- the story of Beer.

Philanthropic activitiesIn 2004, Kiran started the Biocon Foundation to conduct health, education, sanitation, and environmental programs to benefit of the economically weaker sections of society.All the clinics maintained by Biocon organize regular general health checks in remote villages by bringing in physicians and doctors from network hospitals. Each year, the Foundation touches more than 300,000 lives through its holistic healthcare approach.She helped establish a 1,400-bed cancer care center at the Narayana Health City campus at Boommasandra in 2007.

Personal Recognition19821983198919992002200520092010

BIOCONIndias Leading Biotech enterpriseEstablished in 1978Focus on development of Bio-pharmaceuticals1stin Asia & 16th in world in terms of revenue and market capitalizationSyngene, Indias first bio-tech custom research company in drug discoveryFirst company to manufacture human insulin Using a Pichia expression system Indias first billion dollar bio-tech company Biocon's key innovations include insulin analogue Glargine, BASALOGand India's first indigenously produced monoclonal antibody BioMAb-EGFR, for head & neck cancer. INSU Penis a next generation affordable insulin delivery device introduced in India by Biocon.

Journey of Biocon Under her wings..

In 1978 itself, she started Biocon in he garage in Bangalore with a capital of Rs. 10,000.

In 1978, she joined Biocon Biochemicals Limited, of Cork, Ireland as a Trainee Manager.

Within a year, Biocon became the first Indian company to manufacture and export enzymes to USA and Europe.

In 1990, she upgraded Biocons in-house research program, based on a proprietary solid substrate fermentation technology.

The commercial success of this program led to a three-fold expansion by 1996 and Biocon entered the biopharmaceuticals and statins segments

In 1998, when Unilever agreed to sell its shareholding in Biocon to the Indian promoters, Biocon became an independent entity.

Within a year, Biocon became the first Indian company to manufacture and export enzymes to USA and Europe.

In 1990, she upgraded Biocons in-house research program, based on a proprietary solid substrate fermentation technology.

By 2003 Biocon became the first company worldwide to develop human insulin on a Pichia expression system.

In 2000, Biocon's proprietary bioreactor, christened PlafractorTM, based on solid matrix fermentation received a U.S. patent.

In 2004, she decided to access the capital markets to develop Biocons pipeline of research programs.

Biocons IPO was oversubscribed 32 times and its first day at the bourses closed with a market value of $1.11 billion.

It made Biocon the 2nd only company to cross $1 billion mark on the first day of listing.

She entered into more than 2,200 high-value R&D licensing and other deals within the pharmaceuticals and bio-pharmaceutical space between 2005 & 2010

Biocons state of the art Human Insulin Facility

Business in BIOCONSplit Business Technique(SBT)Divided business:Syngene - company dealing in laboratory setups and micro-biological reasearch

Clinigene clinical research organisation

Biocon biotechnology products

All these companies are owned by Kiran M. Shaw which makes her the richest lady in India.

Departments of BioconTop ManagementMiddle level ManagementHRMFINANCEMARKETTINGOPERATIONSITQA & QCPACKAGINGREGULATORY AFFAIRS

HRM in Biocon Biocon employees approximately 3600 qualified personnel. 15% of Biocon are women The average age of employees is 29 years.

Products Of BioconAnti-Diabetic AgentsAnti-Hypertensive AgentsAnti-Inflammatory AgentsAntioxidantsCardiovascular AgensDigestive Aid EnzymesHaemostatic AgentsHepatoprotective AgentsImmunosuppressantsNutraceuticals

Financial FrontThe paid up capital of Syngene as on March 31st, 2009 is Rs.28,750,000.The paid up capital of Clinigene as on March 31st, 2009 is Rs.500,000.The subscribed capital on 31st, 2008 of Axicorp is 7,950,000.The paid up capital of BBPL as on March 31st 2009 is Rs. 176,000,000.The paid up capital of NeoBiocon as on March 31st 2009 is 45,250,000.SHARE PRICE 228.95 (BSE)

Biocons AchievementMed Ad News, in its 2007/08 listings has ranked Biocon 20th amongst the leading biotechnology companies in the world.Med Ad News, in its 2007/08 listings also ranked Biocon as 7th Largest Employer in the world.Biocon also recently received the 2009 Bio Singapore Asia Pacific Biotechnology Award for Best Listed Company